PUBLISHER: BIS Research | PRODUCT CODE: 1637364
PUBLISHER: BIS Research | PRODUCT CODE: 1637364
Europe Genome Sequencing Market: Focus on Product, End User, and Country - Analysis and Forecast: 2024-2033
Introduction to Europe Genome Sequencing Market
The Europe genome sequencing market was valued at $2.22 billion in 2024 and is expected to reach $7.23 billion by 2033, growing at a CAGR of 14.04% between 2024 and 2033. Through the process of identifying the entire sequence of an organism's DNA, genome sequencing allows scientists to decipher its entire genetic composition. This process helps identify genetic variations and their potential impact on health and disease. The genome sequencing market in Europe is expanding due to factors such as the decreasing cost of sequencing, increasing adoption of genome testing, and the growing demand for prenatal and newborn screening programs that leverage next-generation sequencing technologies.
The expanding applications of long-read sequencing, which provide more detailed and accurate insights into complex genetic information, further drive market growth. In addition, government investments and initiatives in genome sequencing projects across Europe have significantly boosted accessibility and adoption.
| KEY MARKET STATISTICS | |
|---|---|
| Forecast Period | 2024 - 2033 |
| 2024 Evaluation | $2.22 Billion |
| 2033 Forecast | $7.23 Billion |
| CAGR | 14.04% |
As the area keeps its attention on developments in healthcare and precision medicine, genome sequencing is becoming a critical tool for improving diagnostics, personalized treatments, and disease prevention. These trends are set to shape the future of the genome sequencing market in Europe, ensuring continued innovation and wider consumer access.
Market Introduction
The growing demand for genetic testing, the growing use of precision medicine, and improvements in sequencing technologies are all contributing to the notable growth of the European genome sequencing market. An increasingly important tool in research, diagnostics, and individualized healthcare is genome sequencing, which decodes an organism's entire DNA sequence.
As next-generation sequencing (NGS) becomes more widely available and sequencing costs decline, the technology becomes more accessible, facilitating its integration into European healthcare systems. Prenatal and neonatal screening, cancer diagnosis, rare disease detection, and pharmacogenomics are important uses.
The market is being further stimulated by government programs and investments in genomic research projects, such as the UK's 100,000 Genomes Project. More precise and thorough genetic analysis is now possible thanks to the growing use of long-read sequencing technologies, improving clinical outcomes.
As Europe continues to prioritize innovation in healthcare, the genome sequencing market is set to play a pivotal role in advancing medical research and delivering personalized treatments.
Market Segmentation
Segmentation 1: by Product
- Kits
- Instruments
- Software
Segmentation 2: by End User
- Pharmaceutical and Biotechnology Companies
- Hospitals and Diagnostic Laboratories
- Population Sequencing Organizations
- Research and Academic Institutes
- Others
Segmentation 3: by Region
- Europe
- Germany
- U.K.
- Spain
- Italy
- France
- Rest-of-Europe
How can this report add value to an organization?
Product/Innovation Strategy: The Europe genome sequencing market has been segmented based on various categories, such as by product, end user, and country. This can help readers get a clear overview of which segments account for the largest share and which ones are well-positioned to grow in the coming years.
Competitive Strategy: The Europe genome sequencing market is a highly fragmented market, with many public and few private companies. Key players in the genome sequencing market analyzed and profiled in the study involve established players that offer various kinds of products.
Key Market Players and Competition Synopsis
The companies that are profiled have been selected based on inputs gathered from primary experts and analyzing company coverage, product portfolio, and market penetration.
Some prominent names established in this market are:
- Eurofins Scientific S.E.
- F. Hoffmann-La Roche Ltd.
- OncoDNA
- Oxford Nanopore Technologies plc
- QIAGEN N.V.
Table of Contents
Executive Summary
Scope and Definition
1 Europe Genome Sequencing Market: Industry Analysis
- 1.1 Key Trends: Current and Future Impact Assessment
- 1.1.1 Integration of Artificial Intelligence and Machine Learning in Genome Sequencing
- 1.1.2 Increasing Partnerships, Alliances, and Business Expansions among Key Players
- 1.2 Regulatory Analysis
- 1.3 Value and Supply Chain Analysis
2 Europe Genome Sequencing Market: Future Outlook
- 2.1 Patent Analysis
- 2.1.1 Patent Analysis (by Year)
- 2.1.2 Patent Analysis (by Country)
- 2.2 Competitive Benchmarking
- 2.2.1 Market Share
- 2.2.2 Brand Recognition
- 2.3 Sequencing Clinical Adoption
- 2.4 Future Outlook
3 Genome Sequencing Market (By Region)
- 3.1 Regional Summary
- 3.2 Drivers and Restraints
- 3.3 Europe
- 3.3.1 Regional Overview
- 3.3.2 Driving Factors for Market Growth
- 3.3.3 Factors Challenging the Market
- 3.3.4 By Product
- 3.3.5 By End User
- 3.3.6 Germany
- 3.3.6.1 By Product
- 3.3.7 U.K.
- 3.3.7.1 By Product
- 3.3.8 Spain
- 3.3.8.1 By Product
- 3.3.9 Italy
- 3.3.9.1 By Product
- 3.3.10 France
- 3.3.10.1 By Product
- 3.3.11 Rest-of-Europe
- 3.3.11.1 By Product
4 Genome Sequencing Market - Competitive Benchmarking and Company Profiles
- 4.1 Key Strategies and Development
- 4.1.1 Partnerships, Alliances, and Business Expansions
- 4.1.2 Regulatory and Legal Activities
- 4.1.3 New Offerings
- 4.1.4 Mergers and Acquisitions
- 4.1.5 Funding Activities
- 4.2 Company Profiles
- 4.2.1 Eurofins Scientific S.E.
- 4.2.1.1 Overview
- 4.2.1.2 Top Products and Services
- 4.2.1.3 Top Competitors
- 4.2.1.4 Key Personnel
- 4.2.1.5 Analyst View
- 4.2.2 F. Hoffmann-La Roche Ltd.
- 4.2.2.1 Overview
- 4.2.2.2 Top Products and Services
- 4.2.2.3 Top Competitors
- 4.2.2.4 Key Personnel
- 4.2.2.5 Analyst View
- 4.2.3 OncoDNA
- 4.2.3.1 Overview
- 4.2.3.2 Top Products and Services
- 4.2.3.3 Top Competitors
- 4.2.3.4 Key Personnel
- 4.2.3.5 Analyst View
- 4.2.4 Oxford Nanopore Technologies plc
- 4.2.4.1 Overview
- 4.2.4.2 Top Products and Services
- 4.2.4.3 Top Competitors
- 4.2.4.4 Key Personnel
- 4.2.4.5 Analyst View
- 4.2.5 QIAGEN N.V.
- 4.2.5.1 Overview
- 4.2.5.2 Top Products and Services
- 4.2.5.3 Top Competitors
- 4.2.5.4 Key Personnel
- 4.2.5.5 Analyst View
- 4.2.1 Eurofins Scientific S.E.
5 Research Methodology
- 5.1 Data Sources
- 5.1.1 Primary Data Sources
- 5.1.2 Secondary Data Sources
- 5.1.3 Data Triangulation
List of Figures
- Figure 1: Europe Genome Sequencing Market, $Billion, 2024, 2028, and 2033
- Figure 2: Genome Sequencing Market (by Region), $Billion, 2023, 2027, and 2033
- Figure 3: Europe Genome Sequencing Market (by End User), $Billion, 2023, 2027, and 2033
- Figure 4: Europe Genome Sequencing Market (by Product), $Billion, 2023, 2027, and 2033
- Figure 5: Key Players' Strategic Priorities
- Figure 6: Potential Future Directions
- Figure 7: Companies Utilizing Artificial Intelligence in Genomics
- Figure 8: Share of Partnerships, Alliances, and Business Expansions vs Other Strategies
- Figure 9: Some of the Key Partnerships, Alliances, and Business Expansions and their Impact on the Sequencing Market
- Figure 10: Value and Supply Chain Analysis, Genome Sequencing Market
- Figure 11: Genome Sequencing Market, Patent Analysis (by Year), January 2021-December 2023
- Figure 12: Genome Sequencing Market, Patent Analysis (by Country), January 2021-December 2023
- Figure 13: Europe Genome Sequencing Market, Market Share, 2023
- Figure 14: Clinical Utility of Genome Sequencing
- Figure 15: Future Outlook for Genome Sequencing
- Figure 16: Germany Genome Sequencing Market, $Billion, 2023-2033
- Figure 17: U.K. Genome Sequencing Market, $Billion, 2023-2033
- Figure 18: Spain Genome Sequencing Market, $Billion, 2022-2023
- Figure 19: Italy Genome Sequencing Market, $Billion, 2023-2033
- Figure 20: France Genome Sequencing Market, $Billion, 2023-2033
- Figure 21: Partnerships, Alliances, and Business Expansions Activities, January 2020-April 2024
- Figure 22: Regulatory and Legal Activities, January 2020-April 2024
- Figure 23: New Offerings, January 2020-April 2024
- Figure 24: Mergers and Acquisitions, January 2020-April 2024
- Figure 25: Funding Activities, January 2020-April 2024
- Figure 26: Data Triangulation
- Figure 27: Assumptions and Limitations
List of Tables
- Table 1: Market Snapshot
- Table 2: Genome Sequencing Market, Market Opportunities
- Table 3: Current and Future Impact of Trends
- Table 4: Regulatory Landscape (by Country)
- Table 5: Comparison of Some of the Key Sequencers
- Table 6: Genome Sequencing Market (by Region), $Billion, 2023-2033
- Table 7: Europe Genome Sequencing Market (by Product), $Billion, 2023-2033
- Table 8: Canada Genome Sequencing Market (by End User), $Billion, 2023-2033
- Table 9: Germany Genome Sequencing Market (by Product), $Billion, 2023-2033
- Table 10: U.K. Genome Sequencing Market (by Product), $Billion, 2023-2033
- Table 11: Spain Genome Sequencing Market (by Product), $Billion, 2023-2033
- Table 12: Italy Genome Sequencing Market (by Product), $Billion, 2023-2033
- Table 13: France Genome Sequencing Market (by Product), $Billion, 2023-2033
- Table 14: Rest-of-Europe Genome Sequencing Market, $Billion, 2023-2033
- Table 15: Rest-of-Europe Genome Sequencing Market (by Product), $Billion, 2023-2033
- Table 16: Europe Genome Sequencing Market, Key Development Analysis, January 2020-April 2024
